Non-Hodgkin Lymphoma

MD IQ

News

Bortezomib may overcome resistance in WM

Bortezomib may help overcome treatment resistance in patients with Waldenström’s macroglobulinemia (WM) and CXCR4 mutations, according to a new...

News

Combo appears safe, active in rel/ref NHL

The combination of Hu5F9-G4 (5F9) and rituximab was considered safe and produced durable complete responses (CRs) in patients with relapsed or...

Pages